does semaglutide cause diarrhea after eating side effects for diabetes and obesity treatment 🫠 Semaglutides aka Wegovy and

Lillys Retatrutide: Toward the End of Incremental Metabolic Medicine Why GLP-1++ therapies are redefining what is worth developing and what is not In early December 2025, Eli Lilly announced landmark Phase 3 results for retatrutide its investigational once-weekly triple hormone receptor agonist targeting GLP-1, GIP, and glucagon

This could help patients who need a lower dose to avoid side effects or those who require a stronger dose for better blood sugar control or more significant weight loss

Notably, treatment of GLP-1 receptor knock-out mice with AC3174 had no effect on body weight or on the above-mentioned hepatic and plasma parameters [8], indicating the mediating effect of GLP-1 receptor on NAFLD-related parameters

This is when blood glucose levels fall low

Older weight loss injections are also available but are less effective and require more frequent dosing, making them rarely worth considering today